Home › Type 2 Diabetes › New Mexico › Albuquerque
Pag-aaral pangklinika para sa Type 2 Diabetes sa Albuquerque, NM
Isang pag-aaral para sa Type 2 Diabetes ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Albuquerque. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Nagre-recruitPhase 3
- New Mexico Clinical Research and Osteoporosis Center, Inc., Albuquerque
- IMA Clinical Research Albuquerque, Albuquerque
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Nagre-recruitPhase 3
- Albuquerque Clinical Trials, Albuquerque
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
Nagre-recruitPhase 3
- Albuquerque Clinical Trials Inc., Albuquerque
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Nagre-recruitPhase 3
- Albuquerque Clinical Trials, Inc., Albuquerque
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Nagre-recruitPhase 3
- Albuquerque Clinical Trials, Inc., Albuquerque
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Nagre-recruitPhase 2
- Albuquerque Clinical Trials Inc, Albuquerque
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Nagre-recruitPhase 3
- Research Site, Albuquerque
Ketogenic Diet and Diabetes Demonstration Project
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- University of New Mexico, Albuquerque
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Nagre-recruitPhase 3
- Research Site, Albuquerque
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Nagre-recruitPhase 3
- Research Site, Albuquerque
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Nagre-recruitPhase 3
- University of New Mexico Hospital, Albuquerque
Pag-aaral para sa Type 2 Diabetes sa ibang lungsod
- San Antonio, TX37 pag-aaral
- Houston, TX31 pag-aaral
- Orlando, FL24 pag-aaral
- Boston, MA20 pag-aaral
- Chicago, IL19 pag-aaral
- Dallas, TX19 pag-aaral
- Miami, FL19 pag-aaral
- Columbus, OH18 pag-aaral
- Las Vegas, NV18 pag-aaral
- Atlanta, GA17 pag-aaral
- San Diego, CA17 pag-aaral
- Los Angeles, CA16 pag-aaral
Iba pang pag-aaral sa Albuquerque
- Non-Small Cell Lung Cancer18 pag-aaral
- Kanser sa Suso17 pag-aaral
- Kanser sa Ovary15 pag-aaral
- Kanser (lahat ng uri)15 pag-aaral
- Kanser sa Baga14 pag-aaral
- Kanser ng Endometrium13 pag-aaral
- Metastatic Cancer12 pag-aaral
- Sakit sa Puso at Ugat ng Dugo10 pag-aaral
- Melanoma9 pag-aaral
- Kanser sa Prostate9 pag-aaral
- Acute Myeloid Leukemia9 pag-aaral
- Chronic Kidney Disease8 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.